Atrás
Precio Repare Therapeutics Inc (RPTX)
Gráfico del Precio de Acciones RPTX
RPTX Dividendos
Repare Therapeutics Inc
$2.65
0.76%
$0.02
Al cierre: Jan 27, 16:00:00 GMT-5
$2.65
0%
$0
Mercado Previo: Jan 28, 06:57:51 GMT-5
Estadísticas clave
Cierre Anterior
$2.63
Precio de apertura
$2.64
Rango del día
$2.62 - $2.65
Rango de 52 semanas
$0.89 - $2.66
Volumen
1.1M
Volumen promedio
1.1M
EPS (TTM)
-1.69
Rendimiento de dividendos
--
Cap. de mercado
$113.9M
¿Qué es RPTX?
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company is headquartered in St-Laurent, Quebec and currently employs 129 full-time employees. The company went IPO on 2020-06-19. The firm utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
